Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

NORE1A Regulates MDM2 Via β-TrCP

View through CrossRef
Mouse Double Minute 2 Homolog (MDM2) is a key negative regulator of the master tumor suppressor p53. MDM2 regulates p53 on multiple levels, including acting as an ubiquitin ligase for the protein, thereby promoting its degradation by the proteasome. MDM2 is oncogenic and is frequently found to be over-expressed in human tumors, suggesting its dysregulation plays an important role in human cancers. We have recently found that the Ras effector and RASSF (Ras Association Domain Family) family member RASSF5/NORE1A enhances the levels of nuclear p53. We have also found that NORE1A (Novel Ras Effector 1A) binds the substrate recognition component of the SCF-ubiquitin ligase complex β-TrCP. Here, we now show that NORE1A regulates MDM2 protein levels by targeting it for ubiquitination by SCF-β-TrCP. We also show the suppression of NORE1A protein levels enhances MDM2 protein expression. Finally, we show that MDM2 can suppress the potent senescence phenotype induced by NORE1A over-expression. Thus, we identify a mechanism by which Ras/NORE1A can modulate p53 protein levels. As MDM2 has several important targets in addition to p53, this finding has broad implications for cancer biology in tumor cells that have lost expression of NORE1A due to promoter methylation.
Title: NORE1A Regulates MDM2 Via β-TrCP
Description:
Mouse Double Minute 2 Homolog (MDM2) is a key negative regulator of the master tumor suppressor p53.
MDM2 regulates p53 on multiple levels, including acting as an ubiquitin ligase for the protein, thereby promoting its degradation by the proteasome.
MDM2 is oncogenic and is frequently found to be over-expressed in human tumors, suggesting its dysregulation plays an important role in human cancers.
We have recently found that the Ras effector and RASSF (Ras Association Domain Family) family member RASSF5/NORE1A enhances the levels of nuclear p53.
We have also found that NORE1A (Novel Ras Effector 1A) binds the substrate recognition component of the SCF-ubiquitin ligase complex β-TrCP.
Here, we now show that NORE1A regulates MDM2 protein levels by targeting it for ubiquitination by SCF-β-TrCP.
We also show the suppression of NORE1A protein levels enhances MDM2 protein expression.
Finally, we show that MDM2 can suppress the potent senescence phenotype induced by NORE1A over-expression.
Thus, we identify a mechanism by which Ras/NORE1A can modulate p53 protein levels.
As MDM2 has several important targets in addition to p53, this finding has broad implications for cancer biology in tumor cells that have lost expression of NORE1A due to promoter methylation.

Related Results

Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes.
Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes.
Abstract Background. The ubiquitin ligase protein MDM2 plays an important role in cellular processes like growth arrest, senescence and apoptosis, and one of its mai...
Abstract 1645: Discovery of AMG 232, an inhibitor of the MDM2-p53 interaction: From lead to a clinical candidate
Abstract 1645: Discovery of AMG 232, an inhibitor of the MDM2-p53 interaction: From lead to a clinical candidate
Abstract The p53 tumor suppressor is controlled by MDM2, which binds p53 and negatively regulates its transcriptional activity and stability. Many tumors overproduce...
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
Abstract Background The tumor suppressor gene p53 is involved in multiple cellular pathways including apoptosis, transcriptional control, and cel...
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract Mdmx is upregulated in many human cancers. As a member of the Mdm2 protein family, Mdmx functions similar to Mdm2 as a negative regulator of the tumor suppr...
Predicting MDM2 Amplification in Well-Differentiated Liposarcomas
Predicting MDM2 Amplification in Well-Differentiated Liposarcomas
Background: Well-Differentiated Liposarcoma (WDLPS) is the most common subtype of malignant lipomatous tumours. This low-grade neoplasm carries a risk of local recurrence and dedif...

Back to Top